Issued:
Publication of
In compliance with Listing Rule 9.6.1 of the
The Company is applying the exemption available to it under the Disclosure and Transparency Rules 6.3.5(1A) and has made the regulated information available in unedited full text on the NSM, rather than setting out the full text of the regulated information within this announcement.
A copy of the Company's Annual Report in respect of the year ended
V A Whyte
Company Secretary
* https://www.gsk.com/en-gb/company/codes-standards-and-reports/#gsk-capital-plc-annual-reports
Cautionary statement regarding forward-looking statements
GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described in the "Risk Factors" section in GSK's Annual Report on Form 20-F for 2024.
Registered in
No. 2258699
Registered Office:
WC1A 1DG
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the